Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Captiva DSR Pantoprazole and Domperidone Capsules
Captiva DSR, provided by Lexaro Healthcare, combines Pantoprazole and Domperidone in a capsule formulation. Each capsule is designed to provide high-quality, effective treatment for gastrointestinal disorders.
Uses of Captiva DSR Pantoprazole and Domperidone Capsules
Captiva DSR is primarily prescribed for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and other gastrointestinal disorders. It helps to reduce gastric acid production and improves gastrointestinal motility, providing relief from symptoms such as heartburn, acid reflux, and indigestion.
Benefits of Captiva DSR Pantoprazole and Domperidone Capsules
Provides effective relief from heartburn, acid reflux, and indigestion.
Promotes healing of gastric and duodenal ulcers.
Enhances gastrointestinal motility, reducing symptoms of bloating and fullness.
Convenient dosing regimen for improved patient compliance.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Captiva DSR Pantoprazole and Domperidone Capsules
Pantoprazole is a proton pump inhibitor (PPI) that inhibits the production of gastric acid by blocking the proton pump in gastric parietal cells. Domperidone is a dopamine antagonist that enhances gastrointestinal motility by acting on dopamine receptors in the gut. Together, they provide effective relief from acid-related gastrointestinal disorders by reducing acid production and improving gut motility.